Cosmo Pharmaceuticals N.V.
General ticker "CMOPF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $1.1B (TTM average)
Cosmo Pharmaceuticals N.V. follows the US Stock Market performance with the rate: 40.7%.
Estimated limits based on current volatility of 5.5%: low 120.79$, high 134.95$
Factors to consider:
- Company pays dividends (annually): last record date 2025-06-05, amount 2.40$ (Y1.97%)
Short-term CMOPF quotes
Long-term CMOPF plot
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | €266.79MM |
| Operating Expenses | €117.91MM |
| Operating Income | €148.88MM |
| Non-Operating Income | €4.49MM |
| Interest Expense | €0.13MM |
| R&D Expense | €0.37MM |
| Income(Loss) | €153.37MM |
| Taxes | €20.18MM |
| Profit(Loss)* | €133.24MM |
| Stockholders Equity | €498.33MM |
| Inventory | €13.51MM |
| Assets | €646.77MM |
| Operating Cash Flow | €162.41MM |
| Capital expenditure | €5.65MM |
| Investing Cash Flow | €-128.88MM |
| Financing Cash Flow | €-40.22MM |
| Earnings Per Share** | €8.14 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.